2 recruiting, 2 unknown, 1 not yet recruiting. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Lin Zhao: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions Super High-Pressure Non-Compliant Balloon, Intravascular Lithotripsy System - Vascular Calcification | Not applicable | Not yet recruiting | Lin Zhao | 162 | 2026-01-01 | 2025-12-29 |
| FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion FAPl lmaging - Chronic Total Occlusion (CTO), Chronic Coronary Syndrome | Recruiting | Lin Zhao | 470 | 2025-04-15 | 2025-06-19 | |
| FAPI Imaging Assessment of Chronic Total Occlusion FAPI Imaging - Chronic Total Occlusion (CTO) | Recruiting | Lin Zhao | 167 | 2024-09-10 | 2024-10-24 | |
| Chronic Total Occlusive Lesions CMR Study Percutaneous coronary intervention - Chronic Total Occlusion, Image | Unknown | Lin Zhao | 400 | 2023-01-20 | 2023-08-01 | |
| Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO) PCSK9 inhibitor, Statin - In-stent Restenosis, Major Adverse Cardiovascular Events | Phase 4 | Unknown | Lin Zhao | 200 | 2022-12-15 | 2023-11-13 |
Coronary Disease (2) · Coronary Artery Disease (1) · Vascular Calcification (1)
Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Percutaneous Coronary Intervention (1) · evolocumab (1)
China (5)